Evaluating Molecular Biomarkers for the Early Detection of Lung Cancer: When Is a Biomarker Ready for Clinical Use? An Official American Thoracic Society Policy Statement

Background: Molecular biomarkers have the potential to improve the current state of early lung cancer detection. The goal of this project was to develop a policy statement that provides guidance about the level of evidence required to determine that a molecular biomarker, used to support early lung...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Respir Crit Care Med
Main Authors: Mazzone, Peter J., Sears, Catherine Rufatto, Arenberg, Doug A., Gaga, Mina, Gould, Michael K., Massion, Pierre P., Nair, Vish S., Powell, Charles A., Silvestri, Gerard A., Vachani, Anil, Wiener, Renda Soylemez
Formato: Artigo
Idioma:Inglês
Publicado em: American Thoracic Society 2017
Assuntos:
American Thoracic Society Documents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5803661/
https://ncbi.nlm.nih.gov/pubmed/28960111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201708-1678ST
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados